SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UPDATE: Raymond James On Cardytics Also Notes Co's 'significant runway for key revenue drivers including MAUs and ARPU', And 'expectation for 20% plus long-term EBITDA margins'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.comDo you like seeing these details as to why an analyst recommended a stock? What could we do to

Benzinga · -